VTGN vs. ACRV
Compare and contrast key facts about VistaGen Therapeutics, Inc. (VTGN) and Acrivon Therapeutics Inc. Common Stock (ACRV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VTGN or ACRV.
Key characteristics
| VTGN | ACRV | |
|---|---|---|
| YTD Return | -48.83% | 41.46% |
| 1Y Return | -20.78% | 56.76% |
| Sharpe Ratio | -0.35 | 0.31 |
| Sortino Ratio | -0.16 | 1.46 |
| Omega Ratio | 0.98 | 1.17 |
| Calmar Ratio | -0.20 | 0.40 |
| Martin Ratio | -0.63 | 1.45 |
| Ulcer Index | 31.65% | 23.60% |
| Daily Std Dev | 57.79% | 110.69% |
| Max Drawdown | -99.20% | -85.34% |
| Current Drawdown | -98.75% | -70.00% |
Fundamentals
| VTGN | ACRV | |
|---|---|---|
| Market Cap | $81.58M | $259.86M |
| EPS | -$0.93 | -$2.72 |
| Total Revenue (TTM) | $875.70K | $1.88M |
| Gross Profit (TTM) | $435.00K | $1.31M |
| EBITDA (TTM) | -$45.31M | -$59.59M |
Correlation
The correlation between VTGN and ACRV is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VTGN vs. ACRV - Performance Comparison
In the year-to-date period, VTGN achieves a -48.83% return, which is significantly lower than ACRV's 41.46% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VTGN vs. ACRV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for VistaGen Therapeutics, Inc. (VTGN) and Acrivon Therapeutics Inc. Common Stock (ACRV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VTGN vs. ACRV - Dividend Comparison
Neither VTGN nor ACRV has paid dividends to shareholders.
Drawdowns
VTGN vs. ACRV - Drawdown Comparison
The maximum VTGN drawdown since its inception was -99.20%, which is greater than ACRV's maximum drawdown of -85.34%. Use the drawdown chart below to compare losses from any high point for VTGN and ACRV. For additional features, visit the drawdowns tool.
Volatility
VTGN vs. ACRV - Volatility Comparison
The current volatility for VistaGen Therapeutics, Inc. (VTGN) is 10.16%, while Acrivon Therapeutics Inc. Common Stock (ACRV) has a volatility of 18.33%. This indicates that VTGN experiences smaller price fluctuations and is considered to be less risky than ACRV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VTGN vs. ACRV - Financials Comparison
This section allows you to compare key financial metrics between VistaGen Therapeutics, Inc. and Acrivon Therapeutics Inc. Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities